Chemistry:Itrocinonide
From HandWiki
Short description: Chemical compound
 | |
| Clinical data | |
|---|---|
| Other names | D5159; 6α,9α-Difluoro-11β,16α,17α-trihydroxy-21-oxa-3-oxoandrosta-1,4-diene-17β-carboxylic acid, ester with ethyl (S)-1-hydroxyethyl carbonate, cyclic (R)-16,17-acetal with butyraldehyde; 6α,9α-Difluoro-11β,16α,17α-trihydroxy-21-oxapregna-1,4-diene-3,20-dione 21-(1-[(ethoxycarbonyl)oxy]ethyl), cyclic (R)-16,17-acetal with butyraldehyde |
| Drug class | Corticosteroid; Glucocorticoid |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C29H38F2O9 |
| Molar mass | 568.611 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Itrocinonide (developmental code name D5159) is a synthetic glucocorticoid corticosteroid which was never marketed.[1][2][3]
References
- ↑ Retrometabolic Drug Design and Targeting. John Wiley & Sons. 29 August 2012. pp. 193–. ISBN 978-1-118-40776-9. https://books.google.com/books?id=Hjxe9jTGUfQC&pg=PT193.
- ↑ Inhaled Steroids in Asthma: Optimizing Effects in the Airways. CRC Press. 19 April 2016. pp. 526–. ISBN 978-0-203-90853-2. https://books.google.com/books?id=ltjKBQAAQBAJ&pg=PA526.
- ↑ New Drugs for Asthma, Allergy and COPD. Karger Medical and Scientific Publishers. 1 January 2001. pp. 95–. ISBN 978-3-8055-6862-3. https://books.google.com/books?id=IFDp2Jq27PgC&pg=PA95.
 |  |
